4.7 Article

Second to fourth digit ratio (2D: 4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study

Journal

BRITISH JOURNAL OF CANCER
Volume 107, Issue 9, Pages 1631-1636

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2012.418

Keywords

breast cancer; hormones; digit ratio; 2D: 4D; prenatal hormones

Categories

Funding

  1. National Health and Medical Research Council [251533, 209057, 504711]
  2. National Breast Cancer Foundation
  3. Cancer Council Victoria
  4. VicHealth

Ask authors/readers for more resources

BACKGROUND: We aimed to assess whether 2D : 4D measures are associated with breast cancer risk. METHODS: We derived the ratio of the lengths of the index and ring fingers (2D : 4D), and right minus left 2D : 4D (Delta(r-l)) from digit lengths measured from photocopies of participants' hands collected during a recent follow-up of the Melbourne Collaborative Cohort Study, a prospective study including 24 469 women. Of the 9044 women with available data, we identified 573 incident breast cancer cases. Hazard ratios (HR) and 95% confidence intervals (CI) for a one standard deviation difference in 2D : 4D measures were obtained from Weibull survival models, and linear regression models were used to examine potential associations between 2D : 4D measures and age at menarche and menopause. RESULTS: We found a direct association between left 2D : 4D and breast cancer risk, an inverse association between Delta(r-l) and risk of breast cancer, but no association between right 2D : 4D and breast cancer risk. Among breast cancer cases, both right 2D : 4D and Delta(r-l) were inversely associated with age at diagnosis. We also observed associations between both right 2D : 4D and Delta(r-l) and age at menopause, with increasing digit ratio measures related to earlier mean age at menopause. CONCLUSION: Digit ratio measures might be associated with breast cancer risk and age at onset of breast cancer. If confirmed in other studies, this suggests that lower exposure or sensitivity to prenatal testosterone might be associated with lower risk of breast cancer. British Journal of Cancer (2012) 107, 1631-1636. doi:10.1038/bjc.2012.418 www.bjcancer.com Published online 18 September 2012 (c) 2012 Cancer Research UK

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available